Company: ATIIU
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001437749-25-004012
Chunk: 1

Company: Archimedes Tech SPAC Partners II Co.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 1.01
Chunk 1
---
 among the Company and each of the officers and directors of the Company; and  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Administrative Services Agreement, dated February 10, 2025, by and between the Company and Archimedes Tech SPAC Sponsors II LLC.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

On February 12, 2025, the Company consummated the IPO, which consisted of 23,000,000 units (the “ Units”), including the exercise in full by the underwriter of an option to purchase up to 3,000,000 Units at the offering price to cover over-allotments. Each Unit consists of one ordinary share, $0.0001 par value (“ Ordinary Share”) and one-half of one redeemable warrant (each, a “ Warrant”) of the Company, with each whole Warrant entitling the holder thereof to purchase one Ordinary Share for $11.50 per share (subject to adjustment). The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $230,000,000.

As of February 12, 2025, a total of $231,150,000 of the net proceeds from the IPO and the Private Placement (as defined below), which amount included $8,050,000 in deferred underwriting commissions, was deposited in a trust account established for the benefit of the Company’s public shareholders. An audited balance sheet as of February 12, 2025 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement will be filed within four (4) business days of the consummation of the IPO.

Item 3.02. Unregistered Sales of Equity Securities.